Newsletter Archive
-
08.05.24 -- From The Bench To The Boardroom
8/5/2024
08/05/24 Life Science Leader Newsletter
-
08.02.24 -- Examining Biopharma's Growth In Developing Countries
8/2/2024
08/02/24 Life Science Leader Newsletter
-
08.02.24 -- First AI Antibody in Humans, Programmable mRNA, Tumor-Infiltrating Lymphocytes and more new episodes!
8/2/2024
08/02/24 Life Science Leader Newsletter
-
07.31.24 -- An Updated Perspective On The Federal Segment
7/31/2024
07/31/24 Life Science Leader Newsletter
-
07.29.24 -- COVID-19 Concerns Reignite With "FLiRT" Variants
7/29/2024
07/29/24 Life Science Leader Newsletter
-
07.26.24 -- The Recipe For Biotech Startup Success
7/26/2024
07/26/24 Life Science Leader Newsletter
-
07.25.24 -- Implementing Optimal Quality Standards To Enhance Development And Manufacturing Process Performance
7/25/2024
07/25/24 Life Science Leader Newsletter
-
07.24.24 -- EU And U.S. State Regulations For AI
7/24/2024
07/24/24 Life Science Leader Newsletter
-
07.22.24 -- AI-Generated Antibodies
7/22/2024
07/22/24 Life Science Leader Newsletter
-
07.19.24 -- Know Your Regulator
7/19/2024
07/19/24 Life Science Leader Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more